메뉴 건너뛰기




Volumn 123, Issue , 2016, Pages 858-894

Oxindole: A chemical prism carrying plethora of therapeutic benefits

Author keywords

Anti cancer; Anti oxidant; Kinase inhibitory activity; Oxindole; Sunitinib

Indexed keywords

ALKALOID DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDIABETIC AGENT; ANTIGESTAGEN; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; METISAZONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NATURAL PRODUCT; OXINDOLE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SPERMICIDAL AGENT; SUNITINIB; TOCERANIB; VASOPRESSIN ANTAGONIST; 2-OXINDOLE; INDOLE DERIVATIVE;

EID: 84982162319     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2016.08.011     Document Type: Review
Times cited : (251)

References (149)
  • 5
    • 84982142394 scopus 로고    scopus 로고
    • [5] https://www.clinicaltrials.gov.
  • 40
    • 84982175411 scopus 로고    scopus 로고
    • [40] http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0015630/.
  • 65
    • 84892659350 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • [65] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 37 (2014), S81–S90.
    • (2014) Diabetes Care , vol.37 , pp. S81-S90
  • 70
    • 84982160137 scopus 로고    scopus 로고
    • [70] https://www.aids.gov/federal-resources/around-the-world/global-aids-overview/.
  • 79
    • 84903539953 scopus 로고    scopus 로고
    • Policy Brief for Heads of Government: the Global Voice on Dementia 2013-2050
    • National
    • [79] NationalPrince, M., Guerchet, M., Prina, M., Policy Brief for Heads of Government: the Global Voice on Dementia 2013-2050. 2013, 1–8.
    • (2013) , pp. 1-8
    • Prince, M.1    Guerchet, M.2    Prina, M.3
  • 112
    • 85057931451 scopus 로고    scopus 로고
    • Biology of the NMDA Receptor
    • CRC Press United States of America
    • [112] VanDongen, A.M., Biology of the NMDA Receptor. 2008, CRC Press, United States of America.
    • (2008)
    • VanDongen, A.M.1
  • 120
    • 84982092973 scopus 로고    scopus 로고
    • [120] https://clinicaltrials.gov/ct2/show/NCT00005042?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=20.
  • 121
    • 84982079092 scopus 로고    scopus 로고
    • [121] https://clinicaltrials.gov/ct2/show/NCT00004868?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=25.
  • 122
    • 84982093089 scopus 로고    scopus 로고
    • [122] https://clinicaltrials.gov/ct2/show/NCT00026260?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=21.
  • 123
    • 84982093087 scopus 로고    scopus 로고
    • [123] https://clinicaltrials.gov/ct2/show/NCT00006013?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=17.
  • 124
    • 84982189042 scopus 로고    scopus 로고
    • [124] https://clinicaltrials.gov/ct2/show/NCT00005862?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=15.
  • 125
    • 84982120771 scopus 로고    scopus 로고
    • [125] https://clinicaltrials.gov/ct2/show/NCT00006001?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=14.
  • 126
    • 84982160218 scopus 로고    scopus 로고
    • [126] https://clinicaltrials.gov/ct2/show/NCT00006014?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=13.
  • 127
    • 84982079416 scopus 로고    scopus 로고
    • [127] https://clinicaltrials.gov/ct2/show/NCT00006247?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=10.
  • 128
    • 84982093082 scopus 로고    scopus 로고
    • [128] https://clinicaltrials.gov/ct2/show/NCT00005642?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=5.
  • 129
    • 84982079422 scopus 로고    scopus 로고
    • [129] https://clinicaltrials.gov/ct2/show/NCT00009919?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=2.
  • 130
    • 84982189033 scopus 로고    scopus 로고
    • [130] https://clinicaltrials.gov/ct2/show/NCT00006003?intr=Semaxanib+OR+Semaxinib+OR+SU5416+OR+Semaxanib&rank=1.
  • 131
    • 84982149710 scopus 로고    scopus 로고
    • [131] https://www.clinicaltrials.gov/ct2/show/NCT00024063?term=SU-6668&rank=3.
  • 132
    • 84982079409 scopus 로고    scopus 로고
    • [132] https://www.clinicaltrials.gov/ct2/show/NCT00024206?term=SU-6668&rank=1.
  • 133
    • 84982189022 scopus 로고    scopus 로고
    • [133] https://www.clinicaltrials.gov/ct2/show/NCT01465464?term=SU-6668&rank=2.
  • 134
    • 84982149697 scopus 로고    scopus 로고
    • [134] https://www.clinicaltrials.gov/ct2/show/NCT00982267?term=SU-14813&rank=1.
  • 135
    • 84982120728 scopus 로고    scopus 로고
    • [135] https://clinicaltrials.gov/ct2/show/NCT00501566?term=SR-121463&rank=2.
  • 136
    • 84982189027 scopus 로고    scopus 로고
    • [136] https://clinicaltrials.gov/ct2/show/NCT00264914?term=SR-121463&rank=3.
  • 137
    • 84982189040 scopus 로고    scopus 로고
    • [137] https://clinicaltrials.gov/ct2/show/NCT00728091?term=SR-121463&rank=6.
  • 138
    • 84982125969 scopus 로고    scopus 로고
    • [138] https://clinicaltrials.gov/ct2/show/NCT00501384?term=SR-121463&rank=7.
  • 139
    • 84982120736 scopus 로고    scopus 로고
    • [139] https://clinicaltrials.gov/ct2/show/NCT00274326?term=SR-121463&rank=8.
  • 140
    • 84982079436 scopus 로고    scopus 로고
    • [140] https://clinicaltrials.gov/ct2/show/NCT01907100?term=NITEDANIB&rank=1.
  • 141
    • 84982079434 scopus 로고    scopus 로고
    • [141] https://clinicaltrials.gov/ct2/show/NCT00668421?term=LESTAURTINIB&rank=1.
  • 142
    • 84982149644 scopus 로고    scopus 로고
    • [142] https://clinicaltrials.gov/ct2/show/NCT00079482?term=LESTAURTINIB&rank=4.
  • 143
    • 84982149643 scopus 로고    scopus 로고
    • [143] https://clinicaltrials.gov/ct2/show/NCT00494585?term=LESTAURTINIB&rank=5.
  • 144
    • 84982079126 scopus 로고    scopus 로고
    • [144] https://clinicaltrials.gov/ct2/show/NCT00084422?term=LESTAURTINIB&rank=6.
  • 145
    • 84982093016 scopus 로고    scopus 로고
    • [145] https://clinicaltrials.gov/ct2/show/NCT00236119?term=LESTAURTINIB&rank=7.
  • 146
    • 84982188955 scopus 로고    scopus 로고
    • [146] https://clinicaltrials.gov/ct2/show/NCT00081601?term=LESTAURTINIB&rank=12.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.